Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells

Activation of the signal transducer and activator of transcription 3 (STAT3) is observed in multiple cancer types, including gastric cancer, and represents a potential drug target for chemotherapy. Currently, clinically available small-molecule inhibitors targeting STAT3 are lacking. Here, we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hailun, Hong, Huang, Zhang, Lulu, Cai, Xiong, Hu, Meng, Cai, Yuepiao, Zhou, Bin, Lin, Jiayuh, Zhao, Chengguang, Hu, Wanle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677376/
https://www.ncbi.nlm.nih.gov/pubmed/29138596
http://dx.doi.org/10.2147/CMAR.S146173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677376/
https://www.ncbi.nlm.nih.gov/pubmed/29138596
http://dx.doi.org/10.2147/CMAR.S146173

Ejemplares similares